The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin.
T Heikkinen, K Laine, P J Neuvonen...
https://pubmed.ncbi.nlm.nih.gov/10847234/Actively Recruiting
Led by Woman's · Updated on 2021-01-11
34
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying the effect of outpatient oral antibiotics on the length of pregnancy after premature rupture of membranes water bag rupture between 18 07 weeks and 22 67 weeks gestation. This trial compares how long pregnancy continues with or without antibiotic treatment, focusing on patients without other pregnancy complications. The study aims to see if antibiotics influence the time until delivery and the number of patients reaching 23 07 weeks gestation. Participants are admitted for a 24-hour hospital observation to ensure no infections or labor signs. Then, they are randomly assigned to receive either a 7-day course of oral antibiotics azithromycin and amoxicillin or no antibiotics. The first antibiotic dose is given in the hospital to monitor side effects. Both groups have weekly outpatient follow-up visits with specialists and will be admitted to the hospital at 23 weeks or earlier if complications arise. Upon readmission at 23 weeks, all receive standard medications and care for fetal and maternal health. During the study, participants have regular exams including ultrasounds, blood tests, and vital sign monitoring. They track symptoms and temperature daily, and adherence to antibiotics is checked by pill counts. The main outcome measured is the latency period, or how long pregnancy continues after membrane rupture, which can range from less than one day up to 112 days. Researchers also monitor how many patients reach 23 weeks. Safety is closely observed, and the study lasts until delivery or complications occur.
CONDITIONS
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
F
Felicia LeMoine, MD
R
Robert C Moore, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Woman's
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Latency Antibiotics (Azithromycin plus Amoxicillin) | No Antibiotics (Expectant Management) |
|---|---|---|
| What it is | Oral azithromycin and amoxicillin given for seven days as a latency antibiotic regimen following diagnosis of previable PPROM between 18 0/7 and 22 6/7 weeks. | Expectant management without antibiotics after diagnosis of previable PPROM, monitoring for clinical outcomes. |
| Role in the trial | Investigational intervention being evaluated for its effect on latency and perinatal outcomes after previable PPROM. | Comparator group receiving no antibiotics, reflecting outcomes under expectant management. |
| Primary use | Used to try to extend the time between PPROM diagnosis and delivery (latency period) and potentially reduce risks such as neonatal infection. | Observation and supportive care only, without deliberate effort to prolong latency with antibiotics. |
| How it is given or performed | Oral azithromycin (500mg once, then 250mg daily for four more days) and amoxicillin (500mg three times daily for seven days) are given for a total of seven days. | No antibiotics are administered. Participants continue expectant management with monitoring. |
| Evidence status | Latency antibiotics have established benefit in reducing neonatal morbidity and prolonging pregnancy in PPROM at later gestations, but there is limited, indirect evidence specifically for previable PPROM (before 23 weeks). This trial is evaluating this specific regimen and gestational age. | Expectant management without antibiotics is associated with a higher risk of infection and earlier delivery in PPROM at later gestations; few data address outcomes when antibiotics are withheld specifically before viability. |
| Important limitations | Most evidence supporting latency antibiotics for PPROM comes from viable gestational ages (after 23 weeks); the effectiveness and risks of antibiotics before viability remain uncertain. | Withholding antibiotics in PPROM after viability is associated with higher risk of infant morbidity, but the impact of no antibiotics in previable PPROM is less well established due to few studies. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 24 hours
Participants are admitted for a 24-hour hospital observation period to monitor for signs of infection, preterm labor, or other complications before enrollment and randomization.
Continuous in-hospital monitoring during observation period
Duration - Up to 5 to 7 days of outpatient antibiotic therapy before 23 weeks gestation (for antibiotic arm)
Participants are randomized to receive either antibiotics (azithromycin and amoxicillin) or no antibiotics prior to discharge. Those in the antibiotic arm receive the first dose in the hospital and continue outpatient antibiotic therapy. Both groups receive counseling and a patient information pamphlet.
1 hospital visit for initial dose and discharge, then weekly outpatient visits until 23 weeks gestation
Duration - Up to 5 weeks (from enrollment to 23 0/7 weeks gestation)
Participants attend weekly outpatient follow-up visits with Maternal-Fetal Medicine specialists to monitor maternal and fetal well-being until 23 0/7 weeks gestation or clinical change.
Weekly outpatient visits including vital signs, physical exams, ultrasounds, and lab tests
Duration - From 23 0/7 weeks gestation until delivery (variable duration)
At 23 0/7 weeks gestation, participants are readmitted for inpatient management including fetal neuroprotective treatment, corticosteroids, antibiotics, and close monitoring until delivery.
Continuous inpatient care with regular ultrasounds and fetal monitoring
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
T Heikkinen, K Laine, P J Neuvonen...
https://pubmed.ncbi.nlm.nih.gov/10847234/Aaron Deutsch, Elana Deutsch, Crystal Totten...
https://pubmed.ncbi.nlm.nih.gov/20233131/Lex W Doyle, Caroline A Crowther, Philippa Middleton...
https://pubmed.ncbi.nlm.nih.gov/19160238/F J Zlatnik, D P Cruikshank, C R Petzold...
https://pubmed.ncbi.nlm.nih.gov/6492031/B M Mercer, M Miodovnik, G R Thurnau...
https://pubmed.ncbi.nlm.nih.gov/9307346/J D Yeast
https://pubmed.ncbi.nlm.nih.gov/11758532/H W Kilbride, D W Thibeault
https://pubmed.ncbi.nlm.nih.gov/11817188/D B Cotton, L M Hill, H T Strassner...
https://pubmed.ncbi.nlm.nih.gov/6691016/G W Amsden
https://pubmed.ncbi.nlm.nih.gov/8851453/Woman's
Lead Sponsor